Skip to content

Effects of grain constituent on postprandial hyperglycemia : placebo-controlled double blind cross-over trial

Effects of grain constituent on postprandial hyperglycemia : placebo-controlled double blind cross-over trial - Effects of grain constituent on postprandial hyperglycemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000017447
Enrollment
20
Registered
2015-05-16
Start date
2015-05-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

The subjects ingested a single intake of the active meal, and ingested a single intake of the placebo meal after 7 days. The subjects ingested a single intake of the placebo meal, and ingested a singl

Sponsors

QOL RD Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Twenty subjects are divided into two groups at each ten subjects as described bilow. 10 subjects whose fasting blood glucose levels are ranged from 110 mg/dl to less than 125 mg/dl .10 subject whose fasting blood glucose levels are ranged to less than 110 mg/dl. 2) Subjects whose BMI are from 20 kg/m2 to less than 28 kg/m2. 3) Subjects whose systolic blood pressure is 139 mmHg or less and diastolic blood pressure is 89 mmHg or less. 4) Subjects whose triglyceride is 50 mg/dl or more and 149 mg/dl or less. 5) Subjects who can make self-judgment and are voluntarily giving written informed consent.

Exclusion criteria

Exclusion criteria: 1) Subjects who take continuous medical treatment. 2) Subjects who are contracting heart disease, liver disease, kidney disease, digestive disease and allergy disease. 3) Subjects with serious infection 4) Subjects with smoking habit 5) Those whose amount of drinking on the 1st is more than 500 ml in beer conversion. 6) Subjects who are doing carbohydrates restricted diet now. 7) Subjects who participate in other clinical trials. 8) Subjects who are not eligible due to physician's judgment.

Design outcomes

Primary

MeasureTime frame
Blood samples were collected before ingestion and 0.5,1,2,3,4 and 5 hours after ingestion.Urine samples were collected before ingestion and accumulation urine samples were pooled during the postprandial reriods for 5 hrs. Primary outcome is postprandial blood glucose

Secondary

MeasureTime frame
Key secondary outcomes are insulin, triglyceride and glucose-dependent insulinotropic polypeptide.

Countries

Japan

Contacts

Public ContactHigashino Nobuyuki

QOL RD Co.,Ltd. CRO Department Food Division

n-higashino@qol-rd.co.jp03-6386-8809

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026